Your session is about to expire
← Back to Search
Clinical Support Tool for Preventing Cognitive Decline (PCOT Trial)
N/A
Recruiting
Research Sponsored by University of Texas Southwestern Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 years
Awards & highlights
PCOT Trial Summary
This trial is testing whether a combination of clinical decision support and team-based care can help reduce blood pressure and prevent cognitive decline in elderly patients.
Who is the study for?
This trial is for people aged 70 or older with high blood pressure, defined as two readings of SBP >= 130 or DBP >=80 in the last 24 months. Participants must be able to communicate in English or Spanish, have visited a primary care provider within the last two years, and own a smartphone or tablet.Check my eligibility
What is being tested?
The PCOT study tests if patients receiving team-based care and using a clinical decision support tool have better blood pressure control and lower rates of mild cognitive impairment compared to those getting usual medical care.See study design
What are the potential side effects?
Since this trial involves non-drug interventions like clinical support tools and team-based care approaches rather than medications, traditional side effects are not applicable. However, there may be indirect effects related to changes in healthcare management.
PCOT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Cognitive Decline
Secondary outcome measures
Mild Cognitive Decline or Dementia
Other outcome measures
BP Above 130/80
Change in quality of life assessment
Combination Pill Use
+5 morePCOT Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment1 Intervention
Home BP data will be averaged each month via OmronConnect app on the patients' smartphone, which is programmed to send home BP readings to MyChart via Apple or Google Health.Participants whose home blood pressure reading average is systolic ≥ 130 and diastolic ≥ 80 will trigger the CDS (Clinical Decision Support) tool to assist their physicians with their blood pressure management. Study Team will not be involved in treatment decision making, it will be determined by subject's treating physician. .
Group II: Usual Care ArmActive Control1 Intervention
Physicians will continue to make decisions about the participant's blood hypertension management as usual without the CDS tool.
Find a Location
Who is running the clinical trial?
University of Texas Southwestern Medical CenterLead Sponsor
1,055 Previous Clinical Trials
1,050,909 Total Patients Enrolled
Duke UniversityOTHER
2,384 Previous Clinical Trials
3,423,535 Total Patients Enrolled
4 Trials studying Cognitive Decline
680 Patients Enrolled for Cognitive Decline
National Institute on Aging (NIA)NIH
1,694 Previous Clinical Trials
28,022,913 Total Patients Enrolled
34 Trials studying Cognitive Decline
23,051 Patients Enrolled for Cognitive Decline
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had high blood pressure readings in the last 2 years.I have seen my primary care doctor in the last 2 years.I do not have recent severe heart issues or organ transplants.I am currently undergoing or have undergone chemotherapy.Your doctors believe you have less than a year to live.I have advanced kidney disease or am on dialysis.I am younger than 70 years old.I have dementia, Alzheimer's, or a major neurological condition.I am 70 years old or older and can understand and agree to the study's procedures.You have a smartphone or tablet.
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care Arm
- Group 2: Intervention Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger